Spencer E. Brightman

Also affiliated with La Jolla Institute for Immunology, University of California San Diego, La Jolla Institute For Molecular Medicine

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination”.

Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination

Scientific Reports(2022)10.1038/s41598-022-20346-w

N/A

0DataRank · unranked

24 citations

Soumik Barman, Alyson Smith, Francesco Borriello, Danielle Chaney, Spencer E. Brightman +12 more

Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4+ T cells

JCI Insight(2022)10.1172/jci.insight.165570

N/A

0DataRank · unranked

15 citations

Martin S. Naradikian, Rukman R. Thota, Angelica Becker, Leslie Montero, Milad Bahmanof +7 more

Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination

Research Square(2022)10.21203/rs.3.rs-1713108/v1

N/A

0DataRank · unranked

1 citations

Soumik Barman, Alyson Smith, Francesco Borriello, Danielle Chaney, Spencer E. Brightman +12 more

Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors

Nature Immunology(2023)10.1038/s41590-023-01543-9

N/A

0DataRank · unranked

79 citations

Angelica Becker, Rukman R. Thota, Martin S. Naradikian, Leila Y. Chihab, Karla Soria Zavala +8 more

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression

Journal of Clinical Investigation(2023)10.1172/jci164258

N/A

0DataRank · unranked

67 citations

Joey Lee, Spencer E. Brightman, Sara McArdle, Samantha Hall, Rukman R. Thota +8 more

Linked CD4 + /CD8 + T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.06.539290

N/A

0DataRank · unranked

2 citations

Joey Lee, Spencer E. Brightman, Sara McArdle, Samantha M. Hall, Rukman R. Thota +7 more

Discovery of a small molecule TLR3 agonist adjuvant

Nature Communications(2025)10.1038/s41467-025-66878-3

N/A

0DataRank · unranked

4 citations

Danica Dong, Etsuro Nanishi, J. Awad, Kimia Abedi, Yoshine Saito +29 more

The spontaneous neoantigen-specific CD4 + T-cell response to a growing tumor is functionally and phenotypically diverse

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012209

N/A

0DataRank · unranked

2 citations

Spencer E. Brightman, Karla Soria Zavala, Manuel Azaid Ordaz-Arias, Navid Djassemi, Rukman R. Thota +9 more